These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 38002597)

  • 1. 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis.
    Heras-Recuero E; Martínez de Bourio-Allona M; Landaeta-Kancev LC; Blázquez-Sánchez T; Torres-Roselló A; Álvarez-Rubio M; Belhaj-Gandar M; Martínez-López JA; Martínez-Dhier L; Llorca J; Largo R; González-Gay MÁ
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of 18F-FDG PET/CT in Patients With Clinical Suspicion of Polymyalgia Rheumatica and Giant Cell Arteritis: A Prospective, Observational, and Cross-sectional Study.
    Emamifar A; Ellingsen T; Hess S; Gerke O; Hviid Larsen R; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Petersen H; Marcussen N; Dahlstrøm M; Toftegaard P; Thye-Rønn P
    ACR Open Rheumatol; 2020 Aug; 2(8):478-490. PubMed ID: 33439554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron Emission Computed Tomography Spectrum of Large Vessel Vasculitis in a Tertiary Center: Differences in 18F-fluorodeoxyglucose Uptake between Large Vessel Vasculitis with Predominant Cranial and Extracranial Giant Cell Arteritis Phenotypes.
    Heras-Recuero E; Landaeta-Kancev LC; Martínez de Bourio-Allona M; Torres-Rosello A; Blázquez-Sánchez T; Ferraz-Amaro I; Castañeda S; Martínez-López JA; Martínez-Dhier L; Largo R; González-Gay MÁ
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.
    Iannuzzi F; Hysa E; Camellino D; Morbelli S; Bauckneht M; Sambuceti G; Cutolo M; Cimmino MA
    Clin Exp Rheumatol; 2023 Apr; 41(4):812-820. PubMed ID: 37073635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
    Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants.
    Colaci M; Dichiara J; Aprile ML; Ippolito M; Schinocca C; Guggino G; Malatino L
    Front Med (Lausanne); 2022; 9():1042620. PubMed ID: 36465900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study.
    Casadepax-Soulet C; Benali K; Crestani B; Piekarski E; Mahida B; Ebstein E; Juge PA; Forien M; Dieudé P; Ottaviani S
    Clin Exp Rheumatol; 2023 Jul; 41(7):1456-1462. PubMed ID: 36533978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of
    Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM
    J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What-A Critical Review.
    Heras-Recuero E; Blázquez-Sánchez T; Landaeta-Kancev LC; Martínez de Bourio-Allona M; Torres-Roselló A; Rengifo-García F; Caraballo-Salazar C; Largo R; Castañeda S; González-Gay MÁ
    Diagnostics (Basel); 2024 Jul; 14(14):. PubMed ID: 39061676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.
    Nielsen BD; Gormsen LC; Hansen IT; Keller KK; Therkildsen P; Hauge EM
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1119-1128. PubMed ID: 29671039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
    Wakura D; Kotani T; Takeuchi T; Komori T; Yoshida S; Makino S; Hanafusa T
    PLoS One; 2016; 11(7):e0158509. PubMed ID: 27384410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.
    van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Jamar F; Slart RHJA; Gheysens O
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1876-1889. PubMed ID: 33372248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
    Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in Diagnosing Polymyalgia Rheumatica and Large-Vessel Vasculitis: A Case-Control Study.
    Desvages A; Hives F; Deprez X; Pierache A; Béhal H; Flipo RM; Paccou J
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-Body [
    Fröhlich M; Serfling S; Higuchi T; Pomper MG; Rowe SP; Schmalzing M; Tony HP; Gernert M; Strunz PP; Portegys J; Schwaneck EC; Gadeholt O; Weich A; Buck AK; Bley TA; Guggenberger KV; Werner RA
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.
    Yamashita H; Kubota K; Takahashi Y; Minaminoto R; Morooka M; Ito K; Kano T; Kaneko H; Takashima H; Mimoiri A
    Mod Rheumatol; 2012 Sep; 22(5):705-11. PubMed ID: 22205118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of
    González-García A; Fabregate M; Serralta G; de Miguel Campo B; Noblejas-Mozo A; Robles-Marhuenda Á;
    Rev Clin Esp (Barc); 2024; 224(7):445-456. PubMed ID: 38852739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of malignancy in patients with suspected polymyalgia rheumatica or giant cell arteritis, examined with FDG-PET/CT.
    Gorlen TF; Brittain JM; Østergaard M; Fischer BM; Døhn UM; Terslev L
    Front Med (Lausanne); 2024; 11():1309905. PubMed ID: 38449885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis.
    Ikuma D; Sawa N; Yamanouchi M; Oba Y; Mizuno H; Suwabe T; Hoshino J; Ubara Y
    Mod Rheumatol; 2024 Mar; 34(3):474-478. PubMed ID: 37279960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of positive
    Prieto-Peña D; Martínez-Rodríguez I; Loricera J; Banzo I; Calderón-Goercke M; Calvo-Río V; González-Vela C; Corrales A; Castañeda S; Blanco R; Hernández JL; González-Gay MÁ
    Semin Arthritis Rheum; 2019 Feb; 48(4):720-727. PubMed ID: 29903537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.